Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Temporary Equity and Stockholders' (Deficit) Equity

v3.22.1
Condensed Consolidated Statements of Temporary Equity and Stockholders' (Deficit) Equity - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Previously Reported [Member]
Reverse Capitalization [Member]
Series A Preferred Stock [Member]
Series A Preferred Stock [Member]
Previously Reported [Member]
Series A Preferred Stock [Member]
Reverse Capitalization [Member]
Series A1 Preferred Stock [Member]
Series A1 Preferred Stock [Member]
Previously Reported [Member]
Series A1 Preferred Stock [Member]
Reverse Capitalization [Member]
Series B Preferred Stock [Member]
Series B Preferred Stock [Member]
Previously Reported [Member]
Series B Preferred Stock [Member]
Reverse Capitalization [Member]
Series C Preferred Stock [Member]
Series C Preferred Stock [Member]
Previously Reported [Member]
Series C Preferred Stock [Member]
Reverse Capitalization [Member]
Series C Convertible Preferred Stock [Member]
Reverse Capitalization [Member]
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Reverse Capitalization [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Reverse Capitalization [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive Loss [Member]
Previously Reported [Member]
Accumulated Other Comprehensive Loss [Member]
Reverse Capitalization [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Accumulated Deficit [Member]
Reverse Capitalization [Member]
Beginning balance at Dec. 31, 2019       $ 20,216,000                                 $ 2,000         $ 135,617,000       $ (1,677,000)         $ (113,726,000)  
Beginning balance, shares at Dec. 31, 2019                                         218                              
Conversion of stock                                     $ 1,000       $ (1,000)                          
Conversion of stock, shares                                     30,064                                  
Ending balance at Mar. 31, 2020         $ 20,216,000                                 $ 3,000         $ 135,616,000       $ (1,677,000)         $ (113,726,000)
Ending balance, shares at Mar. 31, 2020                                           30,282                            
Temporary equity, beginning balance at Dec. 31, 2020       $ 263,895,000 $ 263,895,000   $ 77,562,000 $ 77,562,000   $ 78,621,000 $ 78,621,000   $ 90,910,000 $ 90,910,000   $ 16,802,000   $ 16,802,000                                    
Temporary equity, beginning balance, shares at Dec. 31, 2020             43 7,756   60 7,862   57 9,091   17 2,566                                      
Conversion of stock, shares           7,713     7,802     9,034     2,549                                          
Accrued dividends payable $ (7,393,000)         $ 0           $ 0                     (7,393,000)                          
Temporary equity of accrued dividends payable 7,393,000         $ 2,486,000     $ 2,666,000     $ 2,241,000                                                
Temporary equity of accrued dividends payable, shares           249     267     224                                                
Foreign currency translation adjustment (900,000)                                                     $ (900,000)                
Stock-based compensation 315,000                                           315,000                          
Net loss (1,081,000)                                                             $ (1,081,000)        
Temporary equity, ending balance at Mar. 31, 2021 271,288,000         $ 80,048,000     $ 81,287,000     $ 93,151,000     $ 16,802,000                                          
Temporary equity, ending balance, shares at Mar. 31, 2021           8,005     8,129     9,315     2,566                                          
Ending balance at Mar. 31, 2021 11,157,000                                   $ 3,000       128,538,000         (2,577,000)       (114,807,000)        
Ending balance, shares at Mar. 31, 2021                                     30,282                                  
Beginning balance at Dec. 31, 2021 272,143,000                                   $ 7,000       413,646,000         (3,331,000)       (138,179,000)        
Beginning balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021   $ 260,830,000 $ (11,313,000)                                 $ 7,000       $ 402,034,000 $ (11,612,000)       $ (3,331,000)       $ (137,880,000) $ 299,000    
Beginning balance, shares at Dec. 31, 2021                                     72,027,743                                  
Beginning balance, shares (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021                                       72,027,743                                
Foreign currency translation adjustment (184,000)                                                     (184,000)                
Stock-based compensation 2,050,000                                           2,050,000                          
Common stock issued pursuant to acquisition 23,295,000                                   $ 1,000       23,294,000                          
Common stock issued pursuant to acquisition, shares                                     4,212,246                                  
Net loss (10,907,000)                                                             (10,907,000)        
Ending balance at Mar. 31, 2022 $ 275,084,000                                   $ 8,000       $ 427,378,000         $ (3,515,000)       $ (148,787,000)        
Ending balance, shares at Mar. 31, 2022                                     76,239,989